chr15-64259233-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_022048.5(CSNK1G1):c.190C>T(p.Leu64Phe) variant causes a missense change. The variant allele was found at a frequency of 0.000027 in 1,593,936 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000020 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000028 ( 0 hom. )
Consequence
CSNK1G1
NM_022048.5 missense
NM_022048.5 missense
Scores
3
8
8
Clinical Significance
Conservation
PhyloP100: 4.54
Genes affected
CSNK1G1 (HGNC:2454): (casein kinase 1 gamma 1) This gene encodes a member of the casein kinase I gene family. This family is comprised of serine/threonine kinases that phosphorylate acidic proteins such as caseins. The encoded kinase plays a role in cell cycle checkpoint arrest in response to stalled replication forks by phosphorylating Claspin. A mutation in this gene may be associated with non-syndromic early-onset epilepsy (NSEOE). [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.3651236).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CSNK1G1 | NM_022048.5 | c.190C>T | p.Leu64Phe | missense_variant | 3/12 | ENST00000303052.13 | NP_071331.2 | |
CSNK1G1 | NM_001329605.2 | c.190C>T | p.Leu64Phe | missense_variant | 3/13 | NP_001316534.1 | ||
CSNK1G1 | NM_001329607.2 | c.190C>T | p.Leu64Phe | missense_variant | 3/12 | NP_001316536.1 | ||
CSNK1G1 | NM_001329606.2 | c.190C>T | p.Leu64Phe | missense_variant | 3/12 | NP_001316535.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CSNK1G1 | ENST00000303052.13 | c.190C>T | p.Leu64Phe | missense_variant | 3/12 | 1 | NM_022048.5 | ENSP00000305777 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 151900Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
3
AN:
151900
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000277 AC: 40AN: 1442036Hom.: 0 Cov.: 27 AF XY: 0.0000265 AC XY: 19AN XY: 716694
GnomAD4 exome
AF:
AC:
40
AN:
1442036
Hom.:
Cov.:
27
AF XY:
AC XY:
19
AN XY:
716694
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000197 AC: 3AN: 151900Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74190
GnomAD4 genome
AF:
AC:
3
AN:
151900
Hom.:
Cov.:
31
AF XY:
AC XY:
0
AN XY:
74190
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
0
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 27, 2023 | The c.190C>T (p.L64F) alteration is located in exon 3 (coding exon 2) of the CSNK1G1 gene. This alteration results from a C to T substitution at nucleotide position 190, causing the leucine (L) at amino acid position 64 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;T;T;.;T;T;.;.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D;.;D;D;D;D
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M;.;.;.;.;.;.;.;.
MutationTaster
Benign
D;D
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;.;.;.;.;.;.;.;.
REVEL
Benign
Sift
Uncertain
D;.;.;.;.;.;.;.;.
Sift4G
Uncertain
D;D;D;D;D;D;D;.;.
Polyphen
P;.;P;.;.;.;.;.;.
Vest4
MutPred
Loss of catalytic residue at L64 (P = 0.1363);Loss of catalytic residue at L64 (P = 0.1363);Loss of catalytic residue at L64 (P = 0.1363);Loss of catalytic residue at L64 (P = 0.1363);Loss of catalytic residue at L64 (P = 0.1363);Loss of catalytic residue at L64 (P = 0.1363);Loss of catalytic residue at L64 (P = 0.1363);Loss of catalytic residue at L64 (P = 0.1363);Loss of catalytic residue at L64 (P = 0.1363);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at